Extracellular calcium-sensing receptor: Implications for calcium and magnesium handling in the kidney

Kidney International

Volumn 50, Issue 6, 1996, Pages 2129-2139

  Hebert, Steven C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR;

ADULT; CALCIUM METABOLISM; CASE REPORT; HUMAN; KIDNEY FUNCTION; MAGNESIUM METABOLISM; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; REVIEW;

EID: 0029951194     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.539     Document Type: Article

References (97)

1. 2+-sensing receptor from bovine parathyroid. Nature 366:575-580, 1993
2. RICCARDI D, PARK J, LEE W-S, GAMBA G, BROWN EM, HEBERT SC: Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 92:131-135, 1995
3. GARRETT JE, CAPUANO IV, HAMMERLAND LG, HUNG BCP, BROWN EM, HEBERT SC, NEMETH EF, FULLER F: Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270:12919-12925, 1995
4. RUAT M, MOLLIVER ME, SNOWMAN AM, SNYDER SH: Calcium sensing receptor: Molecular cloning in rat and localization to nerve terminals. Proc Natl Acad Sci USA 92:3161-3165, 1995
5. 2+-sensing receptor cDNA from human kidney. Biochem Biophys Res Comm 214:524-529, 1995
6. BROWN EM, VASSILEV PM, HEBERT SC: Calcium ions as extracellular first messengers. Cell 83:679-682, 1995
7. BROWN EM: Kidney and bone: physiological and pathophysiological relationships, in Handbook of Physiology: Renal Physiology, edited by WINDHAGER EE, New York, Oxford University Press, 1992, p 1841
8. 2+ and other ions as extracellular (first) messengers. Physiol Rev 71:371-411, 1991
9. FRIEDMAN PA, GESEK FA: Cellular calcium transport in renal epithelia: Measurement, mechanisms, and regulation. Physiol Rev 75:429-471, 1995
10. DE ROUFFIGNAC C, QUAMME G: Renal magnesium handling and its hormonal control. Physiol Rev 74:305-322, 1994
11. KUROKAWA K: The kidney and calcium homeostasis. Kidney Int 44:S97-S105, 1994
12. STEWART AF, BROADUS AE: Mineral metabolism, in Endocrinology and Metabolism, edited by BAXTER FP, BROADUS AE, FROHMAN LA, New York, McGraw-Hill, 1987, p 1317
13. AURBACH GD, MARX SJ, SPIEGEL AM: Parathyroid hormone, calcitonin, and calciferols, in Textbook of Endocrinology, edited by WILSON J, FOSTER DW, Philadelphia, Saunders, 1985, p 1137
14. PARFITT AM, KLEERKOPER M: The divalent cation homeostatic system: physiology and metabolism of calcium, phosphorus, magnesium, and bone, in Clinical Disorders of Fluid and Electrolyte Metabolism, edited by MAXWELL MH, KLEEMAN CR, New York, McGraw-Hill, 1980, p 269
15. ROUSE D, SUKI WN: Renal control of extracellular calcium. Kidney Int 38:700-708, 1995
16. KUROKAWA K: Nephrology Forum: Calcium-regulating hormones and the kidney. Kidney Int 32:760-771, 1987
17. BROWN EM, POLLACK M, SEIDMAN CE, SEIDMAN JG, CHOU Y-HW, RICCARDI D, HEBERT SC: Calcium-sensing cell-surface receptors. N Engl J Med 333:234-240, 1995
18. 2+ receptor-dependent regulation of cellular function. News Physiol Sci 10:1-5, 1995
19. LAU K, BOURDEAU JE: Parathyroid hormone action in calcium transport in the distal nephron. Curr Opin Nephrol Hypertens 4:55-63, 1995
20. QUAMME GA: Control of magnesium transport in the thick ascending limb. Am J Physiol (Renal Fluid Electrol Physiol) 256:F197-F210, 1989
21. QUAMME GA, DIRKS JH: Magnesium transport in the nephron. Am J Physiol (Renal Fluid Electrol Physiol) 239:F393-F401, 1980
22. 2+-sensing receptor and PTH/ PTHrP receptor in rat kidney (abstract). J Am Soc Nephrol 6:954, 1995
23. 2+ on renal function? J Am Soc Nephrol 6:1530-1540, 1995
24. MARX SJ, ATTIE MF, STOCK JL, SPIEGEL AM, LEVINE MA: Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab 52:736-740, 1981
25. GILL JR JR, BARTTER FC: On the impairment of renal concentrating ability in prolonged hypercalcemia and hypercalciuria in man. J Clin Invest 40:716-722, 1961
26. 2+ stimulate accumulation of inositol phosphates in bovine parathyroid cells. FEBS Lett 218:113-118, 1987
27. 2+ and the regulation of secretion in parathyroid cells. FEBS Lett 203:15-19, 1986
28. JONES SM, FRINDT G, WINDHAGER EE: Effect of peritubular [Ca] or ionomycin on hydrosmotic response of CCTs to ADH or cAMP. Am J Physiol (Renal Fluid Electrolyte Physiol) 254:F240-F253, 1988
29. 2+ inhibits peptide hormone-dependent cAMP production specifically in thick ascending limbs of Henle. Miner Electrolyte Metab 12:342-346, 1986
30. KUSANO E, MURAYAMA N, WERNESS JL, CHRISTENSEN S, HOMMA S, YUSUFI ANK, DOUSA TP: Effects of calcium on the vasopressin-sensitive cAMP metabolism in medullary tubules. Am J Physiol (Renal Fluid Electrolyte Physiol) 249:F956-F966, 1985
31. 2+ inhibits AVP-dependent cAMP production in thick ascending limbs of Henle. Am J Physiol (Renal Fluid Electrolyte Physiol) 250:F770-F776, 1986
32. DILLINGHAM MA, DIXON BS, ANDERSON RJ: Calcium modulates vasopressin effect in rabbit cortical collecting tubule. Am J Physiol (Renal Fluid Electrolyte Physiol) 252:F115-F121, 1987
33. BROWN EM, FULEIHAN GE-H, CHEN CJ, KIFOR O: A comparison of the effects of divalent and trivalent cations on parathyroid hormone release, 3′, 5′-cyclic-adenosine monophosphate accumulation, and the levels of inositol phosphates in bovine parathyroid cells. Endocrinology 127:1064-1071, 1990
34. NEMETH EF: Regulation of cytosolic calcium by extracellular divalent cations in C-cells and parathyroid cells. Cell Calcium 11:323-327, 1990
35. BROWN EM, BUTTERS R, KATZ C, KIFOR O: Neomycin mimics the effects of high extracellular calcium concentrations on parathyroid function in dispersed bovine parathyroid cells. Endocrinology 128: 3047-3054, 1991
36. 2+ sensing of normal and adenomatous parathyroid cells. Mol Cell Endocrinol 83:211-218, 1992
37. CONKLIN BR, BOURNE HR: Marriage of the flytrap and the serpent. Nature 67:22, 1994
38. HEBERT SC, BROWN EM: The extracellular calcium receptor. Curr Opin Cell Biol 7:484-492, 1995
39. BOCKAERT J: G proteins, G-protein-coupled receptors: Structure, function, and interactions. Curr Opin Neurobiol 1:1132-1142, 1991
40. JACKSON T: Structure and function of G protein coupled receptors. Pharmacol Ther 50:425-442, 1991
41. NAKANISHI S: Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603, 1992
42. O'HARA PJ, SHEPPARD PO, THOGERSEN H, VENEZIA D, HALDEMAN BA, MCGRANE V, HOUAMED KM, THOMSEN C, GILBERT TL, MULVIHILL ER: The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron 11:41-52, 1993
43. TAM R, SAIER MH JR: Structural, functional, and evolutionary relationships among extracellular solute-binding receptors of bacteria. Microbiol Rev 57:320-346, 1993
44. FLIEGEL L, OHNISHI M, CARPENTER MR, KHANNA VK, RETTHMEIER RAF, MACLENNAN DH: Amino acid sequence of rabbit fast-twitch skeletal muscle calsequestrin deduced from cDNA and peptide sequencing. Proc Natl Acad Sci USA 84:1167-1171, 1987
45. LAW WM, HEATH H III: Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med 102:511-519, 1985
46. MARX SJ, ATTIE MF, LEVINE MA, SPIEGEL AM, DOWNS RW JR, LASKER RD: The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 60:235-242, 1981
47. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297-1303, 1993
48. POLLAK MR, CHOU Y-HW, MARX SJ, STEINMANN B, COLE DEC, BRANDI ML, PAPAPOULOS SE, MENKO FH, HENDY GN, BROWN EM, SEIDMAN CE, SEIDMAN JG: Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effect of mutant gene dosage on phenotype. J Clin Invest 93:1108-1112, 1994
49. ESTEP HL, MISTRY Z, BURKE PK: Familial idiopathic hypocalcemia (abstract). 63rd Annu Mtg Endocrine Soc, 1981, p 275
50. 2+-sensing receptor gene mutation. Nature Genet 8:303-307, 1994
51. CHOU Y-H W, BROWN EB, LEVI T, CROWE G, ATKINSON AB, ARNOVIST HJ, TOSS G, FULEIHAN GE-H, SEIDMAN JG, SEIDMAN CE: The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nature Genet 1:295-300, 1992
52. HEATH H III, JACKSON CE, OTTERUD B, LEPPERT MF: Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 53:193-200, 1993
53. TRUMP D, WHYTE MP, WOODING C, PANG JT, KOCHER D, THAKKER RV: Linkage studies in a kindred with hereditary hypercalcemia and increasing parathyroid hormone levels indicate genetic heterogeneity (abstract). J Bone Miner Res 8:S167, 1993
54. HEATH H III: Familial benign hypercalcemia-From clinical description to molecular genetics. West J Med 160:554-561, 1994
55. PEARCE SHS, TRUMP D, WOODING C, BESSER GM, CHEW SL, HEATH DA, HUGHES IA, THAKKER RV: Four novel mutations in the calcium-sensing receptor gene associated with familial benign (hypocalciuric) hypercalcemia (abstract). J Bone Miner Res 9:S145, 1994
56. HEATH H III, ODELBERG S, BROWN D, HILL VM, ROBERTSON M, JACKSON CE, TEH BT, HAYWARD N, LARSSON C, BUIST N, GARRETT J, LEPPERT M: Sequence analysis of the parathyroid cell calcium receptor (CaR) gene in familial benign hypercalcemia (FBH): multiplicity of mutations? (abstract) J Bone Miner Res 9:S414, 1994
57. MARX SJ, LASKER RD, BROWN EB, FITZPATRICK LA, SWEENEY NB, GOLDBLOOM RB, GILLIS DA, COLE DEC: Secretory dysfunction in parathyroid cells from neonate with severe primary hyperparathyroidism. J Clin Endocrinol Metab 62:445-449, 1986
58. KHOSLA S, EBELING PR, FIREK AF, BURRITT MM, KAO PC, HEATH H III: Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 76:715-720, 1993
59. COOPER L, WERTHEIMER J, LEVEY R, BROWN E, LEBOFF M, WILKINSON R, ANAST CS: Severe primary hyperparathyroidism in a neonate with two hypercalcemic parents: management with parathyroidectomy and heterotopic autotransplantation. Pediatrics 78:263-268, 1986
60. ATTIE MF, GILL JR JR, STOCK JL, SPIEGEL AM, DOWNS RW JR, LEVINE MA, MARX SJ: Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. J Clin Invest 72:667-676, 1983
61. QUAMME GA, DIRKS JH: Intraluminal and contraluminal magnesium on magnesium and calcium transfer in the rat nephron. Am J Physiol (Renal Fluid Electrolyte Physiol) 238:F187-F198, 1980
62. DE ROUFFIGNAC C, DISTEFANO A, WITTNER M, ROINEL N, ELALOUF JM: Consequences of differential effects of ADH and other peptide hormones on thick ascending limb of mammalian kidney. Am J Physiol (Regulatory Integrative Comp Physiol) 260:R1023-R1035, 1991
63. HEBERT SC, ANDREOLI TE: Control of NaCl transport in the thick ascending limb. Am J Physiol (Renal Fluid Electrolyte Physiol) 246: F745-F756, 1984
64. GUIGNARD J-P, JONES NF, BARRACLOUGH MA: Effect of brief hypercalcaemia of free water reabsorption during solute diuresis: evidence for impairment of sodium transport in Henle's loop. Clin Sci 39:337-347, 1970
65. MANITIUS A, LEVITIN H, BECK D, EPSTEIN FH: On the mechanism of impairment of renal concentrating ability in hypercalcemia. J Clin Invest 39:693-697, 1960
66. BECK D, LEVITIN H, EPSTEIN FH: Effect of intravenous infusions of calcium on renal concentrating ability. Am J Physiol 197:1118-1120, 1959
67. BECK N, SINGH H, REED SW, MURDAUGH HV, DAVIS BB: Pathogenic role of cyclic AMP in the impairment of urinary concentrating ability in acute hypercalcemia. J Clin Invest 54:1049-1055, 1974
68. SUKI WN, EKNOYAN G, RECTOR FC JR, SELDIN DW: The renal diluting and concentrating mechanism in hypercalcemia. Nephron 6:50-61, 1969
69. TRECHSEL U, EISMAN JA, FISCHER JA, BONJOUR J-P, FLEISCH H: Calcium-dependent, parathyroid hormone-independent regulation of 1,25-dihydroxyvitamin D. Am J Physiol (Endocrinol Metab) 239:E119-E124, 1980
70. 3 by calcium in the parathyroidectomized, parathyroid hormone replete rat. J Bone Miner Res 4:929-935, 1989
71. SHAREGHI GR, AGUS ZS: Magnesium transport in the cortical thick ascending limb of Henle's loop of the rabbit. J Clin Invest 69:759-769, 1982
72. QUAMME GA: Effect of hypercalcemia on renal tubular handling of calcium and magnesium. Can J Physiol Pharmacol 60:1275-1280, 1982
73. TAKAICHI K, KUROKAWA K: Inhibitory guanosine triphosphate-binding protein-mediated regulation of vasopressin action in isolated single medullary tubules of mouse kidney. J Clin Invest 82:1437-1444, 1988
74. BAUM MA, CHATTOPADHYAY N, BROWN EM, RUDDY MK, HOSSELET C, RICCARDI D, HEBERT S, HARRIS HW: Perinatal expression of aquaporins-2 and 3 (APQ2, APQ3) and calcium receptor (RaKCaR) in developing rat kidney collecting duct (CD) (abstract). J Am Soc Nephrol 6:319, 1995
75. CLEMENS TL, MCGLADE SA, GARRETT KP, CRAVISO GL, HENDY GN: Extracellular calcium modulates vitamin D-dependent calbindin-D28k gene expression in chick kidney cells. Endocrinology 124:1582-1584, 1989
76. 2+ transport in the cortical thick ascending limb of Henle's loop of the mouse is a voltage-dependent process. Renal Physiol Biochem 16:157-166, 1993
77. + transport in the cortical and medullary thick ascending limb of the rat nephron: influence of transepithelial voltage. Pflugers Arch 424: 558-560, 1993
78. BOURDEAU JE, BURG MB: Voltage dependence of calcium transport in the thick ascending limb of Henle's loop. Am J Physiol (Renal Fluid Electrolyte Physiol) 236:F357-F364, 1979
79. FRIEDMAN PA: Renal calcium transport: sites and insights. News Physiol Sci 3:17-21, 1988
80. DE ROUFFIGNAC C, ELALOUF J-M, ROINEL N: Physiological control of the urinary concentrating mechanism by peptide hormones. Kidney Int 31:611-620, 1987
81. + channel in thick ascending limb (TAL) (abstract). J Am Soc Nephrol 6:355, 1995
82. + channels in the thick ascending limb of the rat kidney. Am J Physiol (Cell Physiol), in press
83. + channel in TAL of rat kidney. Am J Physiol (Renal Fluid Electrolyte Physiol) 267:F599-F605, 1994
84. EDWARDS BR, BAER PG, SUTTON RAL, DIRKS JH: Micropuncture study of diuretic effects on sodium and calcium reabsorption in the dog nephron. J Clin Invest 52:2418-2427, 1973
85. WANG T, WANG W, KLEIN-ROBBENHAAR J, GIEBISCH G: Effects of glyburide on renal tubule transport and potassium-channel activity. Renal Physiol Biochem 18:169-182, 1995
86. COSTANZO LS, WINDHAGER EE: Calcium and sodium transport by the distal convoluted tubule of the rat. Am J Physiol (Renal Fluid Electrolyte Physiol) 235:F492-F506, 1978
87. COSTANZO LS: Comparison of calcium and sodium transport in early and late distal tubules: effect of amiloride. Am J Physiol (Renal Fluid Electrolyte Physiol) 246:F937-F945, 1984
88. GESEK FA, FRIEDMAN PA: Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. J Clin Invest 90:429-438, 1992
89. BRUNETTE MG, MAILLOUX J, LAJEUNESSE D: Calcium transport through the luminal membrane of the distal tubule. I. Interrelationship with sodium. Kidney Int 41:281-288, 1992
90. PEACOCK M, ROBERTSON WG, NORDIN BEC: Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet 1:384-386, 1969
91. LUNDGREN S, HJÄLM G, HELLMAN PBE, JUHLIN C, RASTAD J, KLARESKOG L, AKERSTRÖM G, RASK L: A protein involved in calcium sensing of human parathyroid and placental cytotrophoblast cells belongs to the LDL-receptor protein. Exp Cell Res 212:344-350, 1994
92. SUN F, RITCHIE C, HASSAGER C, MAERCKLEIN P, FITZPATRICK L: Heterogeneous response to calcium by individual parathyroid cells. J Clin Invest 91:595-601, 1993
93. CLARKE BL, HASSAGER C, FITZPATRICK LA: Regulation of parathyroid hormone release by protein kinase-C independent of extracellular calcium in bovine parathyroid cells. Endocrinology 132:1168-1175, 1993
94. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Endocrinol Metab 81:1598-1606, 1995
95. SIMON DB, NELSON-WILLIAMS C, BIA MJ, ELLISON D, KARET FE, MOLINA AM, VAARA I, IWATA F, CUSHNER HM, KOOLEN M, GAINZA FJ, GITELMAN HJ, LIFTON RP: Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12:1-8, 1996
96. SIMON DB, KARET FE, HAMDAN JM, DIPIETRO A, SANJAD SA, LIFTON RP: Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13:183-188, 1996
97. LEMMINK HH, VAN DEN HEUVEL LPWJ, VAN DIJK HA, MERKX GFM, SMILDE TJ, TASCHNER PEM, MONNENS LAH, HEBERT SC, KNOERS NVAM: Linkage of Gitelman syndrome to the human thiazide-sensitive sodium-chloride cotransporter (hTSC) gene with identification of mutations in three Dutch families. Pediatr Nephrol, in press